GLP-1s can expand market for weight loss surgery: Bernstein

Carol Yepes/Moment via Getty Images

The rising popularity of the GLP-1 class of anti-obesity medications developed by Novo Nordisk (NVO) and Eli Lilly (LLY) can expand the market for weight loss surgeries in the long run, Bernstein said in a research note last week.


Source link

Related Articles

Back to top button